The latest global regulatory news, changes and updates affecting biopharma, including: CDC, FDA, Health Canada, Ono Pharmaceuticals, U.S. Court of Appeals for the Federal Circuit, U.S. Department of Health and Human Services.

The latest global regulatory news, changes and updates affecting biopharma, including: FDA, International Coalition of Medicines Regulatory Authorities.

The latest global regulatory news, changes and updates affecting biopharma, including: Apotex, DoJ, EMA, Glenmark, U.S. House, Senate, South Korea’s Ministry of Food and Drug Safety, Trump administration.

HONG KONG – Japan’s Ministry of Health, Labour and Welfare (MHLW) ended the first half of 2020 by handing out a flurry of approvals to both domestic and international companies across a wide spectrum of indications.

The latest global regulatory news, changes and updates affecting biopharma, including: Alcon, Gilead Sciences, Institute for Clinical and Economic Review, Novartis, SEC.

HONG KONG - Mumbai-based Glenmark Pharmaceuticals Ltd. has been granted manufacturing and marketing approval for the launch of its antiviral drug, favipiravir, for the treatment of mild to moderate COVID-19, a move it deems a “landmark development for COVID-19 patients in India.”

The latest global regulatory news, changes and updates affecting biopharma, including: Auromedics, Bring Entrepreneurial Advancements to Consumers Here In North America, Central Drugs Standard Control Organisation, FDA, Gilead Sciences, Medicines and Healthcare products Regulatory Agency, NIH, Pharmaceutical and Medical Devices Agency, Somerset, Therapeutic Goods Administration, U.S. Patent and Trademark Office.

The latest global regulatory news, changes and updates affecting biopharma, including: Department of Defense, FDA, Minister of Health, National Center for Advancing Translational Sciences, NIH.